Rivaroxaban is an active substance from the group of anticoagulants that inhibits blood clotting. It is mainly used to prevent thromboses and strokes and for the treatment of pulmonary embolisms. Rivaroxaban is taken by mouth in the form of tablets.
Comprehensive documentation for drug registration of Rivaroxaban can be provided by Biesterfeld as referred.
|CAS-No. || Regulatory || Monograph |
|366789-02-8 || ASMF || IH|